Anti-Proliferative Effect of Naringenin through p38-Dependent Downregulation of Cyclin D1 in Human Colorectal Cancer Cells

  • Song, Hun Min (Department of Bioresource Sciences, Andong National University) ;
  • Park, Gwang Hun (Department of Bioresource Sciences, Andong National University) ;
  • Eo, Hyun Ji (Department of Bioresource Sciences, Andong National University) ;
  • Lee, Jin Wook (Department of Bioresource Sciences, Andong National University) ;
  • Kim, Mi Kyoung (Department of Bioresource Sciences, Andong National University) ;
  • Lee, Jeong Rak (Gyeongbuk Institute for Bio-industry) ;
  • Lee, Man Hyo (Gyeongbuk Institute for Bio-industry) ;
  • Koo, Jin Suk (Department of Bioresource Sciences, Andong National University) ;
  • Jeong, Jin Boo (Department of Bioresource Sciences, Andong National University)
  • Received : 2015.03.02
  • Accepted : 2015.04.22
  • Published : 2015.07.01


Naringenin (NAR) as one of the flavonoids observed in grapefruit has been reported to exhibit an anti-cancer activity. However, more detailed mechanism by which NAR exerts anti-cancer properties still remains unanswered. Thus, in this study, we have shown that NAR down-regulates the level of cyclin D1 in human colorectal cancer cell lines, HCT116 and SW480. NAR inhibited the cell proliferation in HCT116 and SW480 cells and decreased the level of cyclin D1 protein. Inhibition of proteasomal degradation by MG132 blocked NAR-mediated cyclin D1 downregulation and the half-life of cyclin D1 was decreased in the cells treated with NAR. In addition, NAR increased the phosphorylation of cyclin D1 at threonine-286 and a point mutation of threonine-286 to alanine blocked cyclin D1 downregulation by NAR. p38 inactivation attenuated cyclin D1 downregulation by NAR. From these results, we suggest that NAR-mediated cyclin D1 downregulation may result from proteasomal degradation through p38 activation. The current study provides new mechanistic link between NAR, cyclin D1 downregulation and cell growth in human colorectal cancer cells.



Supported by : Andong National University, National Research Foundation of Korea (NRF)


  1. Alao, J. P. (2007) The regulation of cyclin D1 degradation: roles in cancer development and the potential for therapeutic invention. Mol. Cancer 6, 24.
  2. Amaro, M. I., Helder Vila-Real, J. R., Eduardo-Figueira, M., Mota- Filipe, H., Sepodes, B. and Ribeiro, M. H. (2009) Anti-inflammatory activity of naringin and the biosynthesised naringenin by naringinase immobilized in microstructured materials in a model of DSS-induced colitis in mice. Food Res. Int. 42, 1010-1017.
  3. Bahnassy, A. A., Zekri, A. R., El-Houssini, S., El-Shehaby, A. M., Mahmoud, M. R., Abdallah, S. and El-Serafi, M. (2004) Cyclin A and cyclin D1 as significant prognostic markers in colorectal cancer patients. BMC Gastroenterol. 4, 22.
  4. Benzeno, S., Lu, F., Guo, M., Barbash, O., Zhang, F., Herman, J. G., Klein, P. S., Rustgi, A. and Diehl, J. A. (2006) Identification of mutations that disrupt phosphorylation-dependent nuclear export of cyclin D1. Oncogene 25, 6291-6303.
  5. Bulzomi, P., Bolli, A., Galluzzo, P., Acconcia, F., Ascenzi, P. and Marino, M. (2012) The naringenin-induced proapoptotic effect in breast cancer cell lines holds out against a high bisphenol a background. IUBMB Life 64, 690-696.
  6. Casanovas, O., Miro, F., Estanyol, J.M., Itarte, E., Agell, N. and Bachs, O. (2000) Osmotic stress regulates the stability of cyclin D1 in a p38SAPK2-dependent manner. J. Biol. Chem. 275, 35091-35097.
  7. Chidambara Murthy, K. N., Kim, J., Vikram, A. and Patil, B. S. (2012) Differential inhibition of human colon cancer cells by structurally similar flavonoids of citrus. Food Chem. 132, 27-34.
  8. Choi, J. S., Park, K. Y., Moon, S. H., Rhee, S. H. and Young, H. S. (1994) Antimutagenic effect of plant flavonoids in the Salmonella assay system. Arch. Pharm. Res. 17, 71-75.
  9. Cushnie, T. P. and Lamb, A. J. (2011) Recent advances in understanding the antibacterial properties of flavonoids. Int. J. Antimicrob. Agents 38, 99-107.
  10. Diehl, J. A., Zindy, F. and Sherr, C. J. (1997) Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its rapid degradation via the ubiquitin-proteasome pathway. Genes Dev. 11, 957-972.
  11. Ekambaram, G., Rajendran, P., Magesh, V. and Sakthisekaran, D. (2008) Naringenin reduces tumor size and weight lost in N-methyl-N'-nitro-N-nitrosoguanidine-induced gastric carcinogenesis in rats. Nutr. Res. 28, 106-112.
  12. Galluzzo, P., Ascenzi, P., Bulzomi, P. and Marino, M. (2008) The nutritional flavanone naringenin triggers antiestrogenic effects by regulating estrogen receptor alpha-palmitoylation. Endocrinology 149, 2567-2575.
  13. Garcia-Lafuente, A., Guillamon, E., Villares, A., Rostagno, M. A. and Martinez, J. A. (2009) Flavonoids as anti-inflammatory agents: implications in cancer and cardiovascular disease. Inflamm. Res. 58, 537-552.
  14. Huang, J. W., Shiau, C. W., Yang, Y. T., Kulp, S. K., Chen, K. F., Brueggemeier, R. W., Shapiro, C. L. and Chen, C. S. (2005) Peroxisome proliferator-activated receptor gamma-independent ablation of cyclin D1 by thiazolidinediones and their derivatives in breast cancer cells. Mol. Pharm. 67, 1342-1348.
  15. Imai, M., Kikuchi, H., Denda, T., Ohyama, K., Hirobe, C. and Toyoda, H. (2009) Cytotoxic effects of flavonoids against a human colon cancer derived cell line, COLO 201: a potential natural anti-cancer substance. Cancer Lett. 276, 74-80.
  16. Kanno, S., Shouji, A., Asou, K. and Ishikawa, M. (2003) Effects of naringin on hydrogen peroxide-induced cytotoxicity and apoptosis in P388 cells. J. Pharmacol. Sci. 92, 166-170.
  17. Kanno, S., Shouji, A., Hirata, R., Asou, K. and Ishikawa, M. (2004) Effects of naringin on cytosine arabinoside (Ara-C)-induced cytotoxicity and apoptosis in P388 cells. Life Sci. 75, 353-365.
  18. Kanno, S., Tomizawa, A., Ohtake, T., Koiwai, K., Ujibe, M., Ishikawa, M. (2006) Naringenin-induced apoptosis via activation of NF-kappaB and necrosis involving the loss of ATP in human promyeloleukemia HL-60 cells. Toxicol Lett. 166, 131-139.
  19. Kato, J., Matsushime, H., Hiebert, S. W., Ewen, M. E. and Sherr, C. J. (1993) Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4. Genes Dev. 7, 331-342.
  20. Kawai, M., Hirano, T., Higa, S., Arimitsu, J., Maruta, M., Kuwahara, Y., Ohkawara, T., Hagihara, K., Yamadori, T., Shima, Y., Ogata, A., Kawase, I. and Tanaka, T. (2007) Flavonoids and related compounds as anti-allergic substances. Allergol. Int. 56, 113-123.
  21. Kuo, S. M. (1997) Dietary flavonoid and cancer prevention: evidence and potential mechanism. Crit. Rev. Oncog. 8, 47-69.
  22. Lee, C. H., Jeong, T. S., Choi, Y. K., Hyun, B. H., Oh, G. T., Kim, E. H., Kim, J. R., Han, J. I. and Bok, S. H. (2001) Anti-atherogenic effect of citrus flavonoids, naringin and naringenin, associated with hepatic ACAT and aortic VCAM-1 and MCP-1 in high cholesterol-fed rabbits. Biochem. Biophys. Res. Commun. 284, 681-688.
  23. Mukhopadhyay, A., Banerjee, S., Stafford, L. J., Xia, C., Liu, M. and Aggarwal, B. B. (2002) Curcumin-induced suppression of cell proliferation correlates with down-regulation of cyclin D1 expression and CDK4-mediated retinoblastoma protein phosphorylation. Oncogene 21, 8852-8861.
  24. Okabe, H., Lee, S. H., Phuchareon, J., Albertson, D. G., McCormick, F. and Tetsu, O. (2006) A critical role for FBXW8 and MAPK in cyclin D1 degradation and cancer cell proliferation. PloS one 1, e128.
  25. Ramos, S. (2007) Effects of dietary flavonoids on apoptotic pathways related to cancer chemoprevention. J. Nutr. Biochem. 18, 427-442.
  26. Ravishankar, D., Rajora, A. K., Greco, F. and Osborn, H. M. (2013) Flavonoids as prospective compounds for anti-cancer therapy. Int J. Biochem. Cell Biol. 45, 2821-2831.
  27. Renugadevi, J. and Prabu, S. M. (2010) Cadmium-induced hepatotoxicity in rats and the protective effect of naringenin. Exp. Toxicol. Pathol. 62, 171-181.
  28. Siegel, R., Ma, J., Zou, Z. and Jemal, A. (2014) Cancer statistics, 2014. CA: Cancer J. Clin. 64, 364.
  29. Spinella, M. J., Freemantle, S. J., Sekula, D., Chang, J. H., Christie, A. J. and Dmitrovsky, E. (1999) Retinoic acid promotes ubiquitination and proteolysis of cyclin D1 during induced tumor cell differentiation. J. Biol. Chem. 274, 22013-22018.
  30. Tanaka, T. (2013) Role of apoptosis in the chemoprevention of cancer. J. Exp. Clin. Med. 5, 89-91.
  31. Thoms, H. C., Dunlop, M. G. and Stark, L. A. (2007) p38-mediated inactivation of cyclin D1/cyclin-dependent kinase 4 stimulates nucleolar translocation of RelA and apoptosis in colorectal cancer cells. Cancer Res. 67, 1660-1669.
  32. Totta, P., Acconcia, F., Leone, S., Cardillo, I. and Marino, M. (2004) Mechanisms of naringenin-induced apoptotic cascade in cancer cells: involvement of estrogen receptor alpha and beta signalling. IUBMB Life 56, 491-499.
  33. van Acker, F. A., Schouten, O., Haenen, G. R., van der Vijgh, W. J. and Bast, A. (2000) Flavonoids can replace alpha-tocopherol as an antioxidant. FEBS Lett. 12, 145-148.
  34. Wang, B. D., Yang, Z. Y., Wang, Q., Cai, T. K. and Crewdson, P. (2006) Synthesis, characterization, cytotoxic activities, and DNA-binding properties of the La(III) complex with Naringenin Schiff-base. Bioorg. Med. Chem. 14, 1880-1888.
  35. Yoon, H., Kim, T. W., Shin, S. Y., Park, M. J., Yong, Y., Kim, D. W., Islam, T., Lee, Y. H., Jung, K. Y. and Lim, Y. (2013) Design, synthesis and inhibitory activities of naringenin derivatives on human colon cancer cells. Bioorg. Med. Chem. Lett. 23, 232-238.

Cited by

  1. Naringenin-Mediated ATF3 Expression Contributes to Apoptosis in Human Colon Cancer vol.24, pp.2, 2016,
  2. Flavonoid intake from vegetables and fruits is inversely associated with colorectal cancer risk: a case–control study in China vol.116, pp.07, 2016,
  3. Role of p38 Signaling Pathway in Pentagastrin-Regulated Cell Proliferation of Colorectal Carcinoma Cell Line HT-29 vol.07, pp.06, 2016,
  4. Enantioselective Modulatory Effects of Naringenin  Enantiomers on the Expression Levels of miR‐17‐3p  Involved in Endogenous Antioxidant Defenses vol.9, pp.3, 2017,
  5. LC-ESI-MS/MS Identification of Biologically Active Phenolic Compounds in Mistletoe Berry Extracts from Different Host Trees vol.22, pp.4, 2017,
  6. Naringenin Ameliorated Kidney Injury through Let-7a/TGFBR1 Signaling in Diabetic Nephropathy vol.2016, 2016,
  7. Naringenin prevents ischaemic stroke damage via anti-apoptotic and anti-oxidant effects vol.44, pp.8, 2017,
  8. New derivative of 2-(2,4-dihydroxyphenyl)thieno-1,3-thiazin-4-one (BChTT) elicits antiproliferative effect via p38-mediated cell cycle arrest in cancer cells vol.24, pp.6, 2016,
  9. Butyrate-mediated acquisition of chemoresistance by human colon cancer cells vol.36, pp.2, 2016,
  10. Cytotoxic Potential and Molecular Pathway Analysis of Silver Nanoparticles in Human Colon Cancer Cells HCT116 vol.19, pp.8, 2018,
  11. Chromatographic Analyses, In Vitro Biological Activities, and Cytotoxicity of Cannabis sativa L. Essential Oil: A Multidisciplinary Study vol.23, pp.12, 2018,
  12. Estrogen Receptor Beta (ERβ) Mediated-CyclinD1 Degradation via Autophagy Plays an Anti-Proliferation Role in Colon Cells vol.15, pp.5, 2015,
  13. Synthesis of Flavanones via Palladium(II)-Catalyzed One-Pot β-Arylation of Chromanones with Arylboronic Acids vol.84, pp.16, 2015,
  14. Augmented Therapeutic Efficacy of Naringenin Through Microemulsion-Loaded Sericin Gel Against UVB-Induced Photoaging vol.21, pp.6, 2015,
  15. Naringenin-Loaded Dipalmitoylphosphatidylcholine Phytosome Dry Powders for Inhaled Treatment of Acute Lung Injury vol.33, pp.4, 2015,
  16. Naringenin loaded multifunctional nanoparticles to enhance the chemotherapeutic efficacy in hepatic fibrosis vol.22, pp.4, 2015,
  17. Naringenin as a Possible Candidate Against SARS-CoV-2 Infection and in the Pathogenesis of COVID-19 vol.16, pp.12, 2015,